Page results
-
The UCLH Maternity Voices Partnership (MVP) is a team of women and their families, commissioners and providers (midwives and doctors) working together to review and contribute to the development of local maternity care.
-
The aim of the Integrated Care Operations is to support the development of patient centred co-ordinated care for UCLH patients through collaborative working across the organisation and with the community, social and primary care.
-
A guide created by The Red Cell Network with expert patient insight from Elaine Tappin, Miriam Santos Freire and Nneka Smith.
-
This page answers common questions about high-intensity focused ultrasound (HIFU) treatment for the prostate.
-
This page explains what to do and what to avoid when your child has had extractions or minor oral surgery.
-
You can make a secure payment using our online portal. It is a convenient way to make a payment for a range of services and is available 24/7. When making a payment you will be directed a secure website hosted by The Access Group, a leading provider of business software. Payments can be made against an invoice raised by the Trust or for a range of other services which are set out when you access the portal.
-
This page aims to provide information about the syndrome haemophagocytic lymphohistiocytosis (HLH).
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
RESPOND is a new rapid access, community-based screening and care planning system for all asylum-seeking families registered with a GP in North Central London.
-
The Inherited White Matter Disorders (IWMD) Diagnostic and Management Service is a formally commissioned highly specialised service. There are seven centres across England. There are three centres…
File results
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2019/77 Discharge and readmittance for patients with no fixed abode
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide